14 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
152812	69	Inhibition of four human serine proteases by substituted benzamidines.	TBA
23294255	114	Development of new cyclic plasmin inhibitors with excellent potency and selectivity.	Philipps University Marburg
	78	Synthesis and evaluation of 2-aryl-4H-3,1-benzoxazin-4-ones as C1r serine protease inhibitors	TBA
18242991	23	Biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s.	Johnson & Johnson Pharmaceutical Research and Development
16460935	39	A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s.	Johnson & Johnson Pharmaceutical Research and Development
15149641	44	A novel series of potent and selective small molecule inhibitors of the complement component C1s.	3-Dimensional Pharmaceuticals
31658420	98	Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding.	Philipps University Marburg
28977749	75	Chemical Approaches to Modulating Complement-Mediated Diseases.	The University of Queensland
29517911	87	Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema.	Bicycle Therapeutics
	18	Novel multi-targeted agents for Alzheimer's disease: Synthesis, biological evaluation, and molecular modeling of novel 2-[4-(4-substitutedpiperazin-1-yl)phenyl]benzimidazoles	Hacettepe University